Publications by authors named "Christoph Strohhofer"
Ambient air pollution is a significant public health concern, known to affect cardiovascular health adversely. Research has identified both long-term and short-term cardiovascular risks associated with various air pollutants, including those linked to acute coronary syndromes. However, the observed effects are rather small, with most data sourced from highly polluted regions.
View Article and Find Full Text PDFBackground: Empagliflozin administered after acute myocardial infarction proofed to improve cardiometabolic parameters and biomarkers, but the impact on cardiac function is still largely unknown. The aim of this post-hoc echocardiographic sub-analysis of the EMMY trial was to provide in-depth echocardiographic analysis on the effects of empagliflozin versus placebo on standard and novel echocardiographic structural and functional parameters after acute myocardial infarction.
Methods: In this post-hoc analysis of the EMMY trial a subset of 313 patients (157 empagliflozin vs.
Article Synopsis
- * A post-hoc analysis focused on 181 patients from the trial examined the relationship between baseline ECG metrics and the cardiac improvements observed with empagliflozin treatment.
- * The analysis revealed that while certain ECG metrics like QRS width and heart rate showed correlations with cardiac parameters, baseline ECG characteristics did not predict the benefits of empagliflozin on NT-proBNP levels or changes in heart function/structure within 26 weeks post-AMI.